Robotic Urologic Surgery: A Technical Masterclass (2018)

Celebration, FL US
November 11, 2018 to November 12, 2018

Robotic Urologic Surgery: A Technical Masterclass provides a structured approach to advanced robotic surgery for conditions of the prostate, kidney, and bladder with an emphasis on radical prostatectomy and partial nephrectomy. This course will also focus on emerging technologies including genomic testing and advanced imaging. Experienced world-class faculty with more than a decade of experience with complex robotic surgery will provide you with instruction to refine your technique and achieve superior results.

The first day will focus on prostate surgery. Specific surgical techniques will be presented in a step-by-step operative outline. Issues such as optimizing outcomes of robotic radical prostatectomy, discussing complications, and tips and tricks of challenging cases. High Definition live transmission of robotic radical prostatectomy by Dr. Vipul Patel will include recent modifications in technique. The second day will be devoted to kidney surgery and bladder surgery. The course will include multiple video segments demonstrating tips and tricks, management of anatomic anomalies and challenging situations, with expert faculty to provide commentary and discussion. Audience participation will be encouraged to ensure one on one interaction. Panel discussions with expert faculty will address methods to recognize and address complications and problems for each of the surgical procedures.

    Target Audience

    • Urologists

    Learning Objectives

    At the conclusion of this course, learners will be able to:

    1. Examine and analyze the surgical techniques and methodology behind complex robotic urologic cancer surgeries such as prostatectomy, cystectomy and partial nephrectomy.
    2. Assess the key complications and outline the intra-operative and post-operative management related to robotic surgery procedures using video-based learning, surgical video and live surgery and expert panel discussion.
    3. Demonstrate current and upcoming protocols for regaining potency and continence following robotic prostatectomy and cystectomy.
    4. Provide a clinical update on treating, diagnosing, and managing complications of localized, regionally advanced, and metastatic urinary cancer.
    5. Provide a clinical update on emerging technologies in prostate cancer including MRI Fusion Biopsy, single port surgery, and genomic testing.
    6. Apply the surgical techniques and methodology behind complex robotic cancer surgeries including partial nephrectomy, robotic prostatectomy, and nephroureterectomy.
    Course summary
    Available credit: 
    • 14.00 AMA PRA Category 1 Credit™
    • 14.00 Non-Physician Participation
    Course opens: 
    04/30/2018
    Course expires: 
    11/12/2021
    Event starts: 
    11/11/2018 - 6:00am
    Event ends: 
    11/12/2018 - 6:00pm
    Price:
    $859.00
    Rating: 
    0

    Coming Soon!

    Florida Hospital Nicholson Center
    404 Celebration Place
    Celebration, FL 34747
    United States

    Travel

    Melia Orlando Suite Hotel
    225 Celebration Pl

    Celebration, FL 34742
    Phone: 1-407-964-7000
    https://www.melia.com/en/hotels/united-states/orlando

    Please call the hotel at 1-407-964-7465 and reference the American Urological Association when making your reservation to receive the special group rate.

    Online reservations cannot obtain the group rate.

    To hold a reservation, a major credit card number must be provided.
    $129 single/double occupancy. Please call 1-407-964-7465 and reference the American Urological Association when making your reservation to receive the special group rate.

    Please note: To receive the discounted group rate, you must call the hotel directly and reference the AUA by Wednesday, October 10, 2018. Online codes are not available.

    Cut-off Date: Wednesday, October 10, 2018. Once the AUA group block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or at this hotel.

    Check-in: 4 p.m.
    Check-out: 11 a.m.

    Parking
    Complimentary self-parking is available at the hotel.

    Transportation

    Car Rental
    Hertz is pleased to offer special discounted car rental rates to AUA course and meeting attendees. Make your reservation online or call 1-800-654-2240. Mention the AUA discount code CV# 04SG0003.

    Course Director

    Vipul Patel, MD, FACS
    Professor of Urology, University of Central Florida
    Medical Director, Global Robotics Institute
    Medical Director, Florida Hospital Cancer Institute Urologic Oncology Program

    Faculty

    Sam Bhayani, MD

    Robert Peter Carroll, MD, MPH

    Rafael Ferreira Coelho, MD
    Chief of Urology, Sao Paulo State Cancer Institute
    University of Sao Paulo School of Medicine
    Sao Paulo, Brazil

    Matthew Randal Cooperberg, MD, MPH

    John Warren Davis, MD
    Associate Professor and Director Urosurgical Prost
    MD Anderson Cancer Center ‐ Department of Urology
    Houston, TX

    James Roscoe Porter, MD
    Director, Robotic Surgery
    Swedish Urology Group
    Seattle, WA

    Raj Som Pruthi, MD
    Professor and Chair
    University of North Carolina

    Bernardo Maria Maria Rocco, MD

    Joseph A. Smith, Jr., MD
    Professor, Department of Urologic Surgery
    Vanderbilt Hospital
    Nashville, TN

    Chandru P. Sundaram, MD
    Professor and program Director
    Director of Minima
    Indiana University Department of Urology
    Indiananapolis, IN

    Samir Taneja, MD
    The James M. and Janet Riha Neissa Professor of Urologic Oncology
    Professor of Urology and Radiology
    Director, Division of Urologic Oncology
    Co‐Director, Smilow Comprehensive Prostate Cancer Institute
    Department of Urology, NYU Langone Medical Center
    New York, NY

    Raju Thomas, MD, FACS, FRCS, MHA
    Professor and Chair
    Tulane University School of Medicine
    Department of Urology
    New Orleans, LA

    Faculty Disclosures
    NameCompanyRoleFinancialReview Date
    Sam B. Bhayani, MDIntuitiveConsultant or AdvisorYes02/11/2018 
    Robert Peter Carroll, MD, MPHNIHScientific Study or TrialYes01/19/2018 
     Department of DefenseScientific Study or TrialYes01/19/2018 
     AUA UpdateLeadership PositionYes01/19/2018 
     Genomic HealthScientific Study or TrialNo01/19/2018 
    Rafael Ferreira Coelho, MDNothing to disclose
    Matthew Randal Cooperberg, MD, MPHDendreonConsultant or AdvisorYes04/03/2018 
     Myriad GeneticsConsultant or AdvisorYes04/03/2018 
     AstellasConsultant or AdvisorYes04/03/2018 
     MDx HealthConsultant or AdvisorYes04/03/2018 
     GenomeDxMeeting Participant or LecturerYes04/03/2018 
    John Warren Davis, MDGenprobeScientific Study or TrialNo04/02/2018 
     JanssenScientific Study or TrialNo04/02/2018 
     GenomeDxScientific Study or TrialYes04/02/2018 
     British Journal of Urology InternationalHealth PublishingYes04/02/2018 
     IntuitiveConsultant or AdvisorYes04/02/2018 
    Vipul Patel, MDSurgical SpecialtiesConsultant or AdvisorYes04/03/2018 
     MimedxConsultant or AdvisorYes04/03/2018 
     GenomeDxConsultant or AdvisorNo04/03/2018 
     TeleflexConsultant or AdvisorYes04/03/2018 
     TitanConsultant or AdvisorYes04/03/2018 
     Genomic HealthConsultant or AdvisorYes04/03/2018 
    James Roscoe Porter, MDIntuitive SurgicalMeeting Participant or LecturerYes02/12/2018 
     CSATsConsultant or AdvisorYes02/12/2018 
    Raj Som Pruthi, MDMDxHealthConsultant or AdvisorYes12/28/2017 
    Bernardo Maria Maria Rocco, MDAB MedicaOther : surgical tutor for robotic surgeryYes04/04/2018 
    Joseph A. Smith, Jr., MDNothing to disclose
    Chandru P. Sundaram, MDJournal of Endourology and VideourologyLeadership PositionYes04/02/2018 
     Sonacare Inc.Scientific Study or TrialNo04/02/2018 
     OnTarget IncScientific Study or TrialNo04/02/2018 
     IAUALeadership PositionNo04/02/2018 
     Society of Academic UrologistsLeadership PositionNo04/02/2018 
     Endourological SocietyLeadership PositionNo04/02/2018 
    Samir Taneja, MDElsevierHealth PublishingYes01/31/2018 
     InsightecConsultant or AdvisorYes01/31/2018 
     Mdx HealthScientific Study or TrialYes01/31/2018 
     BiobotConsultant or AdvisorNo01/31/2018 
    Raju Thomas, MD, FACS, FRCS, MHAGulf South LithotripsyLeadership Position, Investment InterestYes01/05/2018 
     AUA Annual CME CoursesMeeting Participant or LecturerYes01/05/2018 
     Journal of EndourologyHealth Publishing, Consultant or AdvisorNo01/05/2018 
     Journal of UrologyHealth Publishing, Meeting Participant or LecturerNo01/05/2018 
     Urology Gold JournalOther : Review articlesNo01/05/2018 
     OlympusOther : SpeakerYes01/05/2018 
    Education Council Disclosures
    NameCompanyRoleFinancialDate Reviewed
    Michael R. Abern, MDDepartment of Defense Prostate Cancer Research ProgramScientific Study or TrialYes4/2/2018
     American Urological Association Office of EducationConsultant or AdvisorYes4/2/2018
     Department of Defense Prostate Cancer Research ProgramConsultant or AdvisorYes4/2/2018
    Sero Andonian, MDLumenisMeeting Participant or Lecturer, Scientific Study or TrialYes4/2/2018
    Timothy Charles Brand, MD Nothing to disclose4/2/2018
    Anthony A. Caldamone, MD Nothing to disclose4/2/2018
    Matthew S. Christman, MD Nothing to disclose3/3/2018
    John D. Denstedt, MDCook UrologyOwner, Product DevelopmentYes4/3/2018
     Endourological SocietyLeadership PositionYes4/3/2018
     Endourological SocietyHealth PublishingYes4/3/2018
    Jody Donaldson Nothing to disclose4/9/2018
    Shelby Englert Nothing to disclose4/9/2018
    Allen Gao, MD, PhDPandomedxLeadership Position, Owner, Product DevelopmentYes4/9/2018
    Matthew Thomas Gettman, MDCOVR MedicalConsultant or AdvisorYes2/27/2018
     Intuitive SurgicalConsultant or AdvisorYes2/27/2018
     Exact SciencesScientific Study or TrialYes2/27/2018
    Howard B. Goldman, MDallerganConsultant or AdvisorYes4/2/2018
     MedtronicConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes4/2/2018
     CookScientific Study or TrialNo4/2/2018
     NuvectraConsultant or AdvisorYes4/2/2018
     AxonicsConsultant or AdvisorYes4/2/2018
     NewUroConsultant or AdvisorYes4/2/2018
     GalvaniConsultant or AdvisorYes4/2/2018
     bionessScientific Study or TrialNo4/2/2018
    William C. Huang, MDPhotocureScientific Study or TrialYes2/22/2018
     Karl StorzScientific Study or TrialYes2/22/2018
    William C. Hulbert, Jr., MD Nothing to disclose4/5/2018
    Brant Inman, MD, MS, FRCSCDendreonScientific Study or TrialNo4/3/2018
     Genentech IncScientific Study or TrialNo4/3/2018
     Combat MedicalConsultant or Advisor, Scientific Study or TrialYes4/3/2018
     FKD TherapiesScientific Study or TrialNo4/3/2018
     NucleixScientific Study or TrialYes4/3/2018
     UrogenScientific Study or TrialYes4/3/2018
    Mark L. Jordan MD,FACS Nothing to disclose3/8/2018
    Martin A. Koyle, MD Nothing to disclose4/3/2018
    Yair Lotan, MDabbottScientific Study or TrialNo4/2/2018
     CepheidConsultant or Advisor, Scientific Study or TrialNo4/2/2018
     Pacific EdgeScientific Study or TrialNo4/2/2018
     FKDScientific Study or TrialNo4/2/2018
     MDxHealthConsultant or Advisor, Scientific Study or TrialYes4/2/2018
     biocancellScientific Study or TrialNo4/2/2018
     GenomeDx Biosciences IncScientific Study or TrialNo4/2/2018
     photocureConsultant or Advisor, Scientific Study or TrialNo4/2/2018
    Nicole Lara Miller, MDBoston Scientific CorporationConsultant or Advisor, Meeting Participant or LecturerYes4/3/2018
     Practical Reviews In UrologyHealth PublishingYes4/3/2018
    Manoj Monga, MD, FACSFortecOtherYes4/3/2018
    Ajay Kumar Nangia, MBBS, FACSAUA NewsLeadership Position, Health PublishingYes4/2/2018
     NIH CCN TrialScientific Study or TrialYes4/2/2018
     Urology Care FoundationLeadership PositionNo4/2/2018
     AUA Health Policy CouncilLeadership PositionNo4/2/2018
     South Central AUALeadership PositionNo4/2/2018
     ASRMLeadership PositionNo4/2/2018
    Curtis Nickel, MDFarr LaboratoriesConsultant or AdvisorYes4/4/2018
     AquinoxScientific Study or TrialNo4/4/2018
     PureTech HealthConsultant or AdvisorYes4/4/2018
     AUAHealth PublishingYes4/4/2018
     NIHScientific Study or TrialYes4/4/2018
     Canadian Institute of Health ResearchScientific Study or TrialYes4/4/2018
     Interface BiologicsConsultant or AdvisorYes4/4/2018
     Alvio TherapeuticsConsultant or AdvisorYes4/4/2018
     Seikagaku CorporationConsultant or AdvisorYes4/4/2018
     MedifocusConsultant or AdvisorYes4/4/2018
     RedLeaf MedicalConsultant or AdvisorYes4/4/2018
    Victor William Nitti, MDAstellasHealth Publishing, Scientific Study or TrialNo4/9/2018
     AllerganHealth Publishing, Scientific Study or TrialNo4/9/2018
     Serenity PharmeuticalsInvestment InterestYes4/9/2018
     MedtronicScientific Study or TrialNo4/9/2018
    Christopher Porter, MD Nothing to disclose1/23/2018
    Ganesh V. Raj, MD, PhDPtaresOwner, Product DevelopmentYes1/31/2018
     C-diagnostics corpConsultant or Advisor, Investment InterestYes1/31/2018
     amgenMeeting Participant or LecturerYes1/31/2018
     Johnson and JohnsonConsultant or Advisor, Owner, Product DevelopmentYes1/31/2018
     AstellasMeeting Participant or LecturerYes1/31/2018
     ASTELLASConsultant or Advisor, Meeting Participant or LecturerYes1/31/2018
     JanssenOwner, Product DevelopmentYes1/31/2018
     BAYERConsultant or Advisor, Meeting Participant or LecturerYes1/31/2018
     SANOFIConsultant or Advisor, Meeting Participant or LecturerYes1/31/2018
     GaudiumRxLeadership Position, Investment Interest, Owner, Product DevelopmentYes1/31/2018
     MedivationConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes1/31/2018
     EtiraRxLeadership Position, Investment Interest, Owner, Product DevelopmentYes1/31/2018
    Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes4/9/2018
     MDx HealthScientific Study or TrialNo4/9/2018
    Lee Richstone, MD Nothing to disclose1/5/2018
    Heather SchultzSUNAMeeting Participant or LecturerYes4/4/2018
     SUNALeadership PositionNo4/4/2018
    Karl-Dietrich Sievert, MD, PhDMedtronicsMeeting Participant or Lecturer, Scientific Study or TrialYes4/10/2018
     AllergenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes4/10/2018
     NeotractMeeting Participant or LecturerYes4/10/2018
     StimguardMeeting Participant or Lecturer, Scientific Study or TrialYes4/10/2018
    Joseph A. Smith Jr., MD Nothing to disclose2/15/2018
    Ryan Patrick Terlecki, MD, FACSAmerican Medical SystemsConsultant or Advisor, OtherYes4/7/2018
     Boston ScientificConsultant or AdvisorYes4/7/2018
     MicroGen DxConsultant or AdvisorYes4/7/2018
     U.S. Department of DefenseScientific Study or TrialYes4/7/2018
    Edouard John Trabulsi, MD, FACSGenomeDxConsultant or AdvisorYes4/2/2018
     JanssenConsultant or Advisor, Meeting Participant or LecturerYes4/2/2018
     PfizerConsultant or Advisor, Meeting Participant or LecturerYes4/2/2018
     MerckMeeting Participant or LecturerYes4/2/2018

    Accreditation
    The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation
    The American Urological Association designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Other Learners
    The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

    Evidence Based Content
    It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

    AUA Disclosure Policy
    All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual's relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

    Resolution of Identified Conflict of Interest
    All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

    • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point-counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
    • Divestiture of the relationship by faculty

    Off-label or Unapproved Use of Drugs or Devices
    It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

    Attendee Information & Policies

    Disclaimer
    The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA).

    Consent to Use of Photographic Images
    Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.

    Audio, Video, Photographic Equipment
    The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

    Reproduction Permission
    Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA.

    Special Assistance/Dietary Needs
    The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

    Available Credit

    • 14.00 AMA PRA Category 1 Credit™
    • 14.00 Non-Physician Participation

    Accreditation Period

    Course opens: 
    04/30/2018
    Course expires: 
    11/12/2021

    Price

    Price:
    $859.00
    Please login or register to take this course.